First Citizens Bank & Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$673K Sell
14,029
-123
-0.9% -$5.29K 0.01% 394
2026
Q1
$520K Sell
14,152
-269
-2% -$12.7K 0.01% 429
2025
Q4
$734K Sell
14,421
-2,043
-12% -$104K 0.02% 359
2025
Q3
$914K Sell
16,464
-940
-5% -$55K 0.02% 302
2025
Q2
$1.2M Sell
17,404
-1,193
-6% -$81.1K 0.02% 256
2025
Q1
$1.29M Buy
18,597
+270
+1% +$22.3K 0.03% 218
2024
Q4
$1.58M Buy
18,327
+1,302
+8% +$141K 0.03% 201
2024
Q3
$2.03M Buy
17,025
+1,039
+6% +$139K 0.04% 189
2024
Q2
$2.28M Buy
15,986
+131
+0.8% +$17.4K 0.04% 178
2024
Q1
$2.04M Sell
15,855
-1,551
-9% -$185K 0.04% 189
2023
Q4
$1.8M Buy
17,406
+1,238
+8% +$122K 0.03% 178
2023
Q3
$1.47M Sell
16,168
-688
-4% -$60.6K 0.03% 176
2023
Q2
$1.36M Buy
16,856
+12,220
+264% +$998K 0.03% 183
2023
Q1
$369K Sell
4,636
-24
-0.5% -$1.7K 0.01% 261
2022
Q4
$315K Sell
4,660
-50
-1% -$2.93K 0.01% 264
2022
Q3
$235K Buy
4,710
+92
+2% +$4.93K 0.01% 281
2022
Q2
$257K Buy
+4,618
New +$256K 0.01% 318

Other funds holding NVO

First Citizens Bank & Trust's NVO Position: Q2 2026 in Review

First Citizens Bank & Trust reduced its Novo Nordisk (NVO) stake by 0.87% in Q2 2026, selling an estimated $5.29K and leaving 14,029 shares worth $673K. The position accounts for 0.01% of the portfolio, ranked #394.

First Citizens Bank & Trust first reported a position in NVO in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.28M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • First Citizens Bank & Trust held 14,029 shares of Novo Nordisk worth $673K as of Q2 2026.
  • First Citizens Bank & Trust sold 123 Novo Nordisk shares in Q2 2026, an estimated $5.29K.
  • Novo Nordisk made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #394 holding.
  • First Citizens Bank & Trust first reported a position in Novo Nordisk in Q2 2022 and has held it in 17 quarters since.
  • First Citizens Bank & Trust's Novo Nordisk position peaked at $2.28M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.